Mackenzie Financial Corp Eli Lilly & CO Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Mackenzie Financial Corp holds 268,904 shares of LLY stock, worth $201 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

268,904

Previous 279,151 3.67%

Holding current value

$201 Million

Previous $253 Million 5.74%

% of portfolio

0.36%

Previous 0.4%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $7.91 Million - $9.84 Million	-10,247 Reduced 3.67%	268,904 $238 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $1.88 Million - $2.36 Million	-2,598 Reduced 0.92%	279,151 $253 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $7.85 Million - $10.5 Million	-13,257 Reduced 4.49%	281,749 $219 Million
Q4 2023 Jan 30, 2024	SELL	$525.19 - $619.13 $23.5 Million - $27.7 Million	-44,713 Reduced 13.16%	295,006 $172 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $6.97 Million - $9.62 Million	16,045 Added 4.96%	339,719 $182 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $18.8 Million - $25.1 Million	53,501 Added 19.8%	323,674 $152 Million
Q1 2023 Apr 24, 2023	BUY	$310.63 - $364.82 $900,516 - $1.06 Million	2,899 Added 1.08%	270,173 $92.8 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $2.69 Million - $3.13 Million	8,366 Added 3.23%	267,274 $97.8 Million
Q3 2022 Oct 07, 2022	BUY	$296.48 - $337.87 $4.41 Million - $5.03 Million	14,878 Added 6.1%	258,908 $83.7 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $18.9 Million - $22.2 Million	67,952 Added 38.59%	244,030 $79.1 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $6.59 Million - $8.19 Million	-28,077 Reduced 13.75%	176,078 $50.4 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $8.4 Million - $10.4 Million	-37,349 Reduced 15.47%	204,155 $56.4 Million
Q3 2021 Nov 08, 2021	SELL	$221.6 - $272.71 $5.21 Million - $6.41 Million	-23,523 Reduced 8.88%	241,504 $55.8 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $4.53 Million - $5.86 Million	-25,087 Reduced 8.65%	265,027 $60.8 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $1.42 Million - $1.84 Million	8,627 Added 3.06%	290,114 $54.2 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $1.56 Million - $2.07 Million	11,988 Added 4.45%	281,487 $47.5 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $4.02 Million - $4.65 Million	27,465 Added 11.35%	269,499 $39.9 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $13.5 Million - $16.3 Million	99,285 Added 69.55%	242,034 $39.7 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $646,917 - $800,699	-5,434 Reduced 3.67%	142,749 $19.8 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $6.26 Million - $7.75 Million	58,544 Added 65.31%	148,183 $19.5 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $542,172 - $589,744	5,077 Added 6.0%	89,639 $10 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $3.27 Million - $3.81 Million	-29,498 Reduced 25.86%	84,562 $9.37 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $2.03 Million - $2.39 Million	-18,264 Reduced 13.8%	114,060 $14.8 Million
Q4 2018 Feb 06, 2019	BUY	$105.9 - $118.64 $8.31 Million - $9.31 Million	78,474 Added 145.73%	132,324 $15.3 Million
Q3 2018 Nov 15, 2018	BUY	$85.86 - $107.31 $867,958 - $1.08 Million	10,109 Added 23.11%	53,850 $5.78 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $1.02 Million - $1.17 Million	13,486 Added 44.57%	43,741 $3.73 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $1.31 Million - $1.55 Million	17,644 Added 139.91%	30,255 $2.34 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $1.03 Million - $1.11 Million	12,611	12,611 $1.07 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Eli Lilly & CO Transaction History